Technical topics and roadmap

Description/objective: To visualise the medication process holistically and across sectors, taking into account international standards

Benefit/added value: Increase in drug therapy safety, cross-sector data exchange

Operationalisation/implementation: Working group, development of recommendations for action for harmonisation or recommendation of certain standards

Required experts / collaboration: HL7, MIO42, ePA, e-prescription, pharmacists (also inpatient)

Description/goal: - 

Benefit/added value: Cross-practitioner analysis of data to identify suspected cases of rare diseases and support their treatment, similar to tumour boards

Operationalisation/implementation: Working group, development of cross-sector journey

Required experts / collaboration: Outpatient + inpatient doctors + ?

Description/goal: Specialist user journey for service providers in oncology (indication tbd)

Benefit/added value: Identification of harmonisation potential in oncology from the perspective of service providers

Operationalisation/implementation: Working group, recommendations for action

Required experts / collaboration: Oncology outpatient & inpatient service providers

Description/goal: Development of a journey for users from the areas of home care, social care centres and discharge management

Benefit/added value: Identification of interoperability gaps and necessary standardisation tasks.

Operationalisation/implementation: Recommendations for standardisation activities in the care sector

Required experts / collaboration: Nursing staff / nursing experts, nursing IT manufacturers

Description/objective: Identification and evaluation of use cases in outpatient care that would gain significant added value through interoperability

Benefit/added value: Based on this, strategies can be developed on how interoperability can be implemented more strongly in outpatient care.

Operationalisation/implementation: Working group, recommendations for action

Required experts / collaboration: outpatient service providers, Mio42/ KBV, gematik

Description/objective: Development of a citizen pathway using the example of a diabetes diary

Benefit/added value: Identification of the added value of interoperability for citizens

Operationalisation/implementation: Working group, recommendations for action

Required experts / collaboration: gematik, Mio42, DDG/ diabetes experts

Description/goal: Development of criteria for infrastructure, access, maintenance, services for central terminology servers together with BfArM and gematik

Benefit/added value: Ease of use, better dissemination of international terminologies in DE

Operationalisation/implementation: Recommendations for action for BfArM and gematik

Required experts / collaboration: BfArM, gematik, terminology experts, users and developers

Timeframe: November 2022 - February 2023

Description/goal: Development of governance for value set providers under the aegis of a value set authority

Benefit/added value: Clear rules for setting up and maintaining coding systems and value lists

Operationalisation/implementation: working group, recommendations for action

Required experts / collaboration: value set provider, BfArM, BMG

Timeframe: HY2 2023

Description/objective: Based on the reference validator provided by gematik, the aim is to work out how and for what purposes future test modules will be made available on a binding basis

Benefit/added value: Test modules can be used to evaluate the correct implementation of applications.

Operationalisation/implementation: Working group, recommendations for action

Required experts/collaboration: Interface development, standardisation, FHIR, primary system development

Timeframe: November 2022 - February 2023

Description/Objective: Development of criteria for the design of test environments for testing new (TI) applicationsBenefit/added value: There is currently no possibility to test new applications in various primary systems in advance.

Benefit/added value: There is currently no possibility to test new applications in various primary systems in advance.

Operationalisation/implementation: Working group, recommendations for action

equired experts/cooperation: Primary system manufacturers, specifiers

Timeframe: HY1 2023

Description/objective: The realisation of TI applications in primary systems is stalling. Various possible solutions (confirmation procedures, control options in productive operation) are to be discussed.

Benefit/added value: Identify acceleration potential for the implementation of TI applications.

Operationalisation/implementation: Working group, recommendations for action

Collaboration/experts required: Gematik, primary system manufacturers, providers of TI applications

Timeframe: HY2 202

Description/objective: Investigation of the current status of the binding nature of ISiK. Identification of acceleration potential

Benefit/added value: Accelerate and strengthen the use of standards in the stationary sector..

Operationalisation/ implementation: working group, recommendations for action

Required experts/cooperation: primary system manufacturers, specialised users, specifiers

Period: HY2 2023

Description/objective: To analyse the current status of the liability of AWST.

Benefit/added value: Accelerate and strengthen the use of standards in the outpatient sector.

Operationalisation/implementation: working group, recommendations for action

Required experts/cooperation: KBV, primary system manufacturers, specifiers

Period: HY1 2023

Description/goal: Development of a FHIR-based device interface

Benefit/added value: Replacement of proprietary solutions from the outpatient sector, internationally reusable interface for industry

Operationalisation/implementation: Development of criteria for FHIR interface, if possible commissioning of service provider for development

Required experts/cooperation: device manufacturer, PVS manufacturer

Timeframe: 3 months from February 2023

Description/objective: Development of criteria and requirements for a standardised data model as a construction kit for data objects in KIM and TIM

Benefit/added value: Dispatch of data in KIM/ TIM (incl. standardisation and structuring).

Operationalisation/implementation: Working group, recommendations for action

Required experts/cooperation: KBV, gematik, manufacturers of TI applications and primary systems, specialist users

Timeframe: HY2 2023

Description/objective: Implementation of the working group's recommendations for action (analysis of the status quo of the "heart failure patient journey".

Benefit/added value: still to be defined

Operationalisation/implementation: still to be defined

Required experts/cooperation: still to be defined

Timeframe: HY2 2024

Description/goal: Continuous development of an IOP strategy and IOP governance for Germany

Benefit/added value: Establishment of clear objectives and rules for cooperation between IOP stakeholders in the German healthcare system.

Operationalisation/implementation: still to be defined

Required experts/cooperation: still to be defined

Timeframe: continuous 2023 - 2024